Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(4R,5R)-5-amino-1-[2-(1,3-benzodioxol-5-yl)ethyl]-4-(2,4,5-trifluorophenyl)piperidin-2-one
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the phenylpiperidine class. It features a piperidinone core with trifluorophenyl and benzodioxole substituents. The molecule is listed as an experimental pharmaceutical and has been referenced in chemical databases but does not have an established clinical use or approved indication. Mechanistic data suggest it may act as an inhibitor of dipeptidyl peptidase enzymes such as DPP-IV (dipeptidyl peptidase 4), DPP8 (dipeptidyl peptidase 8), and DPP9 (dipeptidyl peptidase 9), which are serine proteases involved in immune regulation and metabolic processes[3]. However its pharmacological profile remains largely uncharacterized.
- Other names
- (4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE(4R,5R)-5-amino-1-[2-(2H-1,3-benzodioxol-5-yl)ethyl]-4-(2,4,5-trifluorophenyl)piperidin-2-onePiperidinone-Constrained Phenethylamine 25
02
Targets
DPP9 (Dipeptidyl Peptidase 9)DPP8 (Dipeptidyl peptidase 8)DPP-4 (Dipeptidyl Peptidase-IV)
Beyond the preview
Go deeper on (4R,5R)-5-amino-1-[2-(1,3-benzodioxol-5-yl)ethyl]-4-(2,4,5-trifluorophenyl)piperidin-2-one.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (4R,5R)-5-amino-1-[2-(1,3-benzodioxol-5-yl)ethyl]-4-(2,4,5-trifluorophenyl)piperidin-2-one.